HSHHSH Health Technology Supplier Hub
Home › Suppliers › Cambio › Risk

Cambio: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

Apr 2026: SVT's Uppdrag granskning reported seven deaths where Cambio's Cosmic EHR was cited as a contributing factor in Swedish incident reports; Cambio said patient safety is its top priority and it had no information identifying Cosmic faults as a cause of death.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

No data breaches, cyber incidents or regulator action involving Cambio found in HSH's search of the last 24 months. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

Apr 2026: Swedish incident reports reviewed by SVT linked Cosmic to seven deaths and 646 deviations clearly attributed to the system since the 2024 Sussa rollout; Cambio says it has no information that Cosmic faults caused deaths.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

Mar 2026: a Swedish appeal court ruled nine Sussa regions' amended Cosmic contract an unlawful direct award after Cambio's delayed delivery, fining each region SEK 10m (Cambio reportedly liable). Nov 2025: Region Stockholm and Gotland signed with Cambio.

Researched 10 Nov 2026